A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is
BMC Medical Genomics
While next-generation sequencing (NGS) costs have plummeted in recent years, cost and complexity of computation remain substantial barriers to the use of NGS in routine clinical care. The clinical potential of NGS will not be realized until robust and routine whole genome sequencing data can be accurately rendered to medically actionable reports within a time window of hours and at scales of economy in the 10's of dollars. Results: We take a step towards addressing this challenge, by usingdoi:10.1186/s12920-015-0134-9 pmid:26470712 pmcid:PMC4608296 fatcat:7cum7elswnbgvigo2xqgp6nsjm